1. Medtech Insight
  2. >>Policy & Regulation

Recalls 101: New FDA Guidance Gives Basic Advice On Prepping For, Executing A Recall

 
• By Shawn M. Schmitt

The US FDA’s final guidance is a basic how-to guide for manufacturers to prepare for and roll out a product recall action.

Cut outs of paper man climbing the steps to success in a conceptual image.
• Source: Alamy

A new final guidance document from the US Food and Drug Administration offers manufacturers fundamental advice on how to prepare for and execute a product recall action.

“A firm that initiates a recall because it believes the product to be violative is requested to notify FDA immediately,”...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Recalls

More from Policy & Regulation

UK Trails NHS 10-Year Plan With Launch Imminent

 
• By Ashley Yeo

Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.

New EU Rules Limit Chinese Participation In Medtech Procurement

 
• By Amanda Maxwell

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.

Mexico’s New Procurement Rules Aim To Increase Healthcare Investment, But May Face Legal Trouble

 
• By Francesca Bruce

Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.